Ferrari V D, Lonardi F, Bonciarelli C, Jirillo A, Pavanato G
Dipartimento di Terapie Oncologiche Integrate, Legnago (Verona), Italy.
Support Care Cancer. 1996 Jan;4(1):27-30. doi: 10.1007/BF01769871.
The subjective chemotherapy impact (SCI) test has been widely used to evaluate the quality of life in patients receiving chemotherapy. In this study we have tested the SCI questionnaire as an index of the impact of radiotherapy on quality of life. A group of 25 consecutive cancer patients treated with radiotherapy in our centre were tested. In the first item patients were asked to state the number of days they spent with "discomfort". The second item asked them which days they would like to eliminate altogether because of the unbearable symptoms experienced. SCI questions were asked by the same physician before the start of radiotherapy, at the mid point, at the end and 4 months later. A preliminary assessment of validity and reliability of these two indexes provided satisfactory results; data allowed a clear and discriminating differentiation between patients treated with palliative curative radiotherapy and patients who received "adjuvant" treatment (radiotherapy worsened the quality of life in the latter group).
主观化疗影响（SCI）测试已被广泛用于评估接受化疗患者的生活质量。在本研究中，我们测试了SCI问卷作为放疗对生活质量影响的指标。对我们中心连续25例接受放疗的癌症患者进行了测试。在第一项中，要求患者说明他们经历“不适”的天数。第二项询问他们由于难以忍受的症状，希望完全消除哪些日子。在放疗开始前、中期、结束时以及4个月后，由同一位医生询问SCI问题。对这两个指标的有效性和可靠性进行的初步评估提供了令人满意的结果；数据能够清晰地区分接受姑息性根治性放疗的患者和接受“辅助”治疗的患者（放疗使后一组患者的生活质量恶化）。
